T
he Biomic automated well-reading instrument (Giles Scientific, Inc., Santa Barbara, CA) was originally developed as a new method for automated reading of disk diffusion susceptibility plates (1, 2) with extrapolation to an estimated MIC through regression analysis. It has since been adapted for automated reading of yeast disk diffusion tests (3, 4) and can also be used to interpret colonies on chromogenic agars (5) . The instrument has compared favorably with MIC determinations and category interpretations with the Vitek system and with the gradient diffusion (Etest) method (6, 7) . The versatility of the Biomic instrument could be further expanded if 96-well microtiter plates for identification (ID) and antimicrobial susceptibility testing (AST) could also be accurately read in the instrument. The purpose of this study was to evaluate the accuracy of the Biomic automated well reader in interpreting the results from a variety of AST/ID panels read initially on the MicroScan WalkAway (Siemens, Sacramento, CA) instrument. Four different health care institutions participated by testing both clinical isolates and quality control strains.
MATERIALS AND METHODS
Participating laboratories. The following laboratories participated in the study: Scott & White Memorial Hospital, Temple, TX; Texas Health Arlington Memorial Hospital, Arlington, TX; Marquette General Hospital, Marquette, MI; and Grand River Hospital, Kitchener, Canada.
Test organisms. The participating laboratories tested MicroScan panels with a total of 1,911 clinical isolates in antimicrobial susceptibility tests, 1,276 clinical isolates in identification tests, and 309 tests with QC organisms. All clinical isolate test and quality control panels were read as part of the normal laboratory routine with sequential clinical isolates to eliminate an organism selection bias. Study sites and isolates represented a broad clinical and geographic range. Organism sources consisted of a broad spectrum of clinical human specimens and panel manufacturer-recommended QC strains. Comparative reader method. All MicroScan test panels were read in each laboratory with their routine manufacturer-recommended equipment and methods. Each panel was first incubated and read on the MicroScan Walkaway system. Following completion of reading on the Walkaway system, the panel was then removed from the Walkaway system and read on the Biomic system within 1 h. Photographs of the panels and printed test results were provided to Giles Scientific Inc. by e-mail, fax, or mail, according to the study protocol. No patient demographics were transmitted to Giles Scientific Inc.
Biomic automated well reader. A standard commercially available Biomic V3 microbiology system with the Biomic 2011 software was provided to each participating site by Giles Scientific Inc. This system consisted of the standard Biomic V3 reader cabinet containing light-emitting diode (LED) visible light with a high-resolution color digital camera, a personal computer with the Windows operating system, and Biomic 2010 clinical microbiology software. Additionally, each system included the Biomic automated well reader software module. AST and ID test panels were read on the Biomic after being read on the MicroScan reader employed routinely in that laboratory.
Quality control. QC testing of all panels was performed using MicroScan-recommended ATCC strains for each specific panel type.
Data analysis. All test results were read, interpreted, and recorded using the Biomic software and included MIC, susceptible (S)/intermediate (I)/resistant (R) (SIR) category calls, genus/species identification, and panel image. This information was transferred to Giles Scientific for analysis by secure internet upload to the Giles Scientific website. Printed paper copies of MicroScan test results were provided to Giles Scientific and were manually entered into a master Biomic database. Data were verified by Giles Scientific by using the data verification procedure (9), described as follows. (i) MicroScan MIC results were recorded manually using the Biomic software, which uses the Microsoft Access database format. (ii) All test results were divided into two groups: one containing exact MIC matches and the other containing MIC discrepancies. (iii) For the test results group with MIC discrepancies, each test result was verified independently by two persons to check for possible transcription errors. (iv) For the test results group with an exact MIC match between MicroScan and Biomic, we adopted ANSI/ASQC Z1.4 sampling plans (9) for quality control. Given the lot size range of 35,001 to 100,000, sampling size code N is used under general inspection. It requires a sample size of 800, acceptance on 0 nonconformity, and rejection on 1 nonconformity. This corresponds to an AQL (acceptable quality level) of 0.015% and an LTPD (lot tolerance percent defective) of 0.37%. It gives a 95% confidence level that the data have 0.015% or below-defective human errors (7 or fewer bad test results). For the 5% tail probabilities, the upper bound for the possible defective data is 0.37% or 174 test results.
Biomic expert system. The Biomic expert system monitors test results that are unusual or unlikely and detects resistance by using combinations of test results from several antibiotics. The expert system applies CLSI recommendations (8) for category call adjustments based on detection of certain resistance mechanisms, such as oxacillin resistance and detection of extended-spectrum beta-lactamase (ESBL)-mediated-resistance. The expert system may present a warning message onscreen to the technologist after a test is read, change an interpretation (S to R) on the results, or suppress a drug result on the printout.
Category and essential agreement definitions. Category agreement means that the category call of susceptible, intermediate, or resistant as determined by CLSI guidelines (8) was achieved between both instruments. Essential agreement means that Biomic results were within Ϯ1 2-fold dilution of the MicroScan results.
Category call error definitions. Minor errors occurred when either system called an antibiotic interpretation as "intermediate" but the other system called it "resistant" or "susceptible." Major errors (MEs) were defined as a MicroScan category call of susceptible when the Biomic category call was resistant. Very major errors (VMEs) occurred when the Biomic system resulted in a susceptible category call but the MicroScan system interpretation was resistant.
RESULTS
A total of 46,176 MicroScan panel antibiotic-organism combinations were read (Table 1) . For MIC panels and antibiotics with 4 or more dilutions, the Biomic category agreement for 3,117 Gramnegative bacteria was 98.4%, with 1.4% minor errors, 0.2% MEs, and no VMEs ( Table 1 ). The Biomic essential agreement was 99.3%. For 5,233 Gram-positive organisms, the Biomic category agreement was 98.7%, with 0.9% minor, 0.3% MEs, and 0.1% VMEs. The Biomic essential agreement for Gram-positive bacteria was 98.3%. Data analysis by antibiotic is listed in Table 2 . Only 5 VMEs were noted: 2 with erythromycin and 1 each with ampicillin, ceftriaxone, and penicillin. All VMEs occurred with Staphylococcus species.
For MicroScan AST breakpoint panels, the Biomic category agreement with 28,993 drug-Gram-negative organism combinations was 98.2%, with 1.4% minor, 0.3% MEs, and 0.1% VMEs (Table 1) . Biomic category agreement with 8,833 drug-Grampositive organism combinations tested with the MicroScan AST breakpoint panel was 96.5%, with 2.7% minor, 0.6% MEs, and 0.2% VMEs. After Biomic expert rule application, this category agreement increased to 98.3% and the VMEs decreased from 22 to 8. The 19 VMEs for Gram-negative organisms and the 22 VMEs for Gram-positive organisms were distributed among the various antibiotics ( Table 3) . When VMEs were evaluated by organism identification ( Table 2 . b See Table 3 .
All 7 of the Gram-positive misidentifications occurred with Staphylococcus species. Intralab instrument reproducibility. Instrument reproducibility was evaluated by reading MicroScan panels 3 successive times in the Biomic instrument. Three sites selected patient isolates, while one site selected QC panels for reproducibility studies. The overall intralaboratory reproducibility was 99.0%.
DISCUSSION
This study has examined the ability of the Biomic automated well reader to provide accurate reading of 96-well overnight MicroScan panels. The Biomic reading of MicroScan AST/ID panels correlated highly to the panel manufacturer's automated instrument reading as performed routinely in each participating laboratory. Minimal numbers of VMEs were noted in the evaluation. Of the VMEs that were noted with Gram-positive bacteria in the analysis of breakpoint panels, 20 of 22 occurred with Staphylococcus. Of the 20 VMEs noted before Biomic expert system application, 9 were identified with cephalosporin antibiotics and 2 with amoxicillin-clavulanate, whose SIR category call would normally be determined by the oxacillin result, which had 100% accuracy in the study. Consequently, after the application of the Biomic expert system, the number of VMEs for Grampositive bacteria dropped to 6. No VME occurred with Gram-negative bacteria and full MIC panels. With Gram-negative breakpoint panels, Pseudomonas was To compare category agreement, raw MIC readings from both Biomic and MicroScan were interpreted by the Biomic software using the latest interpretive CLSI guideline (M2100-S21). To compare category agreement with the expert system, the same set of expert rules were applied to the raw interpretive results using the Biomic software. responsible for 11 of 19 VMEs. The carbapenem antibiotics imipenem (3/1,178) and meropenem (3/424) were the most common VMEs observed, while the remainder of the VMEs were distributed between six different genera. The Biomic interpretation of biochemical reactions for organism identification also resulted in a high degree of accuracy, with more than 98% of first-choice and 99.5% of either first-choice or second-choice identification with both Gram-positive and Gramnegative organisms. For Gram-negative isolates, the majority of discrepancies occurred with Proteus/Morganella (3 of 68), Acinetobacter (2 of 11), or Pseudomonas (8 of 92) spp. The Biomic instrument identified three Pseudomonas aeruginosa isolates as Alcaligenes xylosoxidans, although P. aeruginosa was the second-choice organism. All discrepancies with Gram-positive organisms occurred with Staphylococcus spp. Misidentification of Staphylococcus aureus as a member of the coagulase-negative staphylococci A weakness of the study design was the inability to adjudicate discrepancies since the data was transferred to Giles Scientific Inc. in the form of photographs and MicroScan printouts for analysis. Another potential weakness of the study was the time difference from the final MicroScan reading to the time of the Biomic reading. However, all panels were read within 1 h of being removed from the MicroScan WalkAway instrument, and all MicroScan ID/AST panels required full overnight incubation and were not rapid panels.
An interesting capability of the Biomic instrument is the ability of the microbiologist to see all test well results on a video screen, to make interpretive adjustments as needed, and to save test panel images for supervisory review at a later time. MicroScan automated readers (AutoScan and WalkAway) do not enable users to view the actual image of the panel on screen but only provide a graphic representation of the panel, with positive and negative biochemical reactions and markers to indicate growth in antibiotic-containing wells. In the case of skipped wells or questions about biochemical test reactions, the MicroScan panel must be removed from the instrument for a visual examination. In contrast, the Biomic instrument allows the visual examination to be made in situ to enable manual adjustments of susceptibility results or biochemical reactions for identification.
In conclusion, the Biomic instrument may be useful as a primary automated reader in laboratories where disk diffusion susceptibility tests and identification panels are currently read manually. In those laboratories, it would permit the use of 96-well MicroScan ID/AST panels for testing organisms such as the nonEnterobacteriaceae, where disk diffusion standards have not been established (8) . It could also be used as a backup automated well reader in instances where the primary antimicrobial susceptibility testing instrument is incapacitated. One notable advantage of the Biomic system is the versatility it has to interpret different methodologies, whether they are different susceptibility methods or identification panels. This is an asset that is important in times when budget constraints could limit the ability of a laboratory to purchase different automation platforms. The instrument can also eliminate the factor of reader variability in manually determining the results of various testing methods but still allows for user control.
